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activities (Route II) 
ABSTRACT 
A series of aminoanthraquinone derivatives were synthesized via two reaction steps. The 
starting material of 1,4-dihydroxyanthraquinone (1) was subjected toamination and the major 
product obtained was then further reacted under reduction, methylation and acylation 
separately to produce 2-(butylamino)anthracene-1,4-dione (2), 2-(butylamino)-1-hydroxy-4-
methoxyanthracene-9,10-dione (9), 2-(butylamino)-1,4-dimethoxyanthracene-9,10-dione 
(10), 3-(butylamino)-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-yl-acetate (11), 2-
(butylamino)-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-yl-acetate (12) and 2-
(butylamino)-9,10-dioxo-9,10-dihydroanthracene-1-yl-acetate (13). Aminoanthraquinone13 
exhibitedstrong antimicrobial activities toward Methicillin-Resistant Staphylococcus aureus 
(MRSA), Pseudomonas aeruginosa, Candida albicans and Escherichia coli with MIC values 
of 0.1, 0.1, 0.1 and 0.5 mg/mL respectively. Aminoanthraquinones 9, 10 and 13 showed 
strong cytotoxicity against both MCF-7 (IC50 2.0-11.0μg/mL)and Hep-G2 (IC50 1.1-
14.0μg/mL) cell lines.  
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